Email this article The state of hemostasis in perimenopause and hormonal replacement therapy
- Authors: Repin M.A.1
-
Affiliations:
- St. Petersburg Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation
- Issue: Vol 50, No 1 (2001)
- Pages: 74-79
- Section: Original study articles
- URL: https://journal-vniispk.ru/jowd/article/view/89293
- DOI: https://doi.org/10.17816/JOWD89293
- ID: 89293
Cite item
Full Text
Abstract
The interruption in the ovarianfunctioning goes along with the disturbances of vascular-trombocyte hemostasis: intravascular trombocyte activation increases, trombocyte micro- and macro-aggregates appear. Cyclic hormonal replacement therapy with Femoston, which contains estradiol and didrogesterone, helps to normalize the trombocytogram. Besides that, the addition of progestagen didrogesterone increases the effect of estradiol on micro circular hemostasia.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. A. Repin
St. Petersburg Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
References
Supplementary files
